Bellerophon Therapeutics
BLPH
$0.05130
Share price
-6.90%
Change (1 day)
-99.34%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Total assets
Total assets on the balance sheet as of September 2023 : $4.97 M
According to Bellerophon Therapeutics 's latest financial reports the company's total assets are $4.97 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bellerophon Therapeutics - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $7.93 M | -70.47% |
| 2021-12-31 | $26.87 M | -46.51% |
| 2020-12-31 | $50.23 M | 283.27% |
| 2019-12-31 | $13.1 M | -28.61% |
| 2018-12-31 | $18.36 M | -50.12% |
| 2017-12-31 | $36.81 M | 23.93% |
| 2016-12-31 | $29.7 M | -22.67% |
| 2015-12-31 | $38.4 M | 15.03% |
| 2014-12-31 | $33.39 M | 818.34% |
| 2013-12-31 | $3.63 M | 8.57% |
| 2012-12-31 | $3.34 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $73.21 B | 1,470,355.91% | 🇺🇸 USA |
 Baxter BAX | $28.27 B | 567,805.20% | 🇺🇸 USA |
 Lantheus Holdings LNTH | $1.65 B | 33,062.28% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | $64 M | 1,185.44% | 🇺🇸 USA |